---
$id: https://graph.org.ai/products/commodity/51171983
$type: Product
source: UNSPSC
code: "51171983"
title: "Rabeprazole"
class: "51171900"
classTitle: "Antiulcer and related gastrointestinal GI drugs"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Rabeprazole

**UNSPSC Code**: 51171983
**Class**: [Antiulcer and related gastrointestinal GI drugs](Antiulcer and related gastrointestinal GI drugs.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a proton pump inhibitor with the molecular formula C18H21N3O3S, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 32828355LL, chemically known as 1h-benzimidazole, 2-(((4-(3-methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)- but more generally known as rabeprazole, which bears U.S. NIH Compound Identifier 5029. European Medicines Agency schedules Rabeprazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10229MIG. The term RABEPRAZOLE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 8 No. 3 1994, List 34). World Health Organization schedules rabeprazole in its Anatomical Therapeutic Chemical (ATC) Classification and its WHO-DD or Drug Dictionary. RABEPRAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

